343 related articles for article (PubMed ID: 34502224)
21. T cells: an emerging cast of roles in bipolar disorder.
Chen Z; Huang Y; Wang B; Peng H; Wang X; Wu H; Chen W; Wang M
Transl Psychiatry; 2023 May; 13(1):153. PubMed ID: 37156764
[TBL] [Abstract][Full Text] [Related]
22. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
Sajatovic M; Gerhart C; Semple W
Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
[TBL] [Abstract][Full Text] [Related]
23. Lithium and suicide prevention in bipolar disorder.
Benard V; Vaiva G; Masson M; Geoffroy PA
Encephale; 2016 Jun; 42(3):234-41. PubMed ID: 27000268
[TBL] [Abstract][Full Text] [Related]
24. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
[TBL] [Abstract][Full Text] [Related]
25. Mood stabilizers and ion regulation.
El-Mallakh RS; Huff MO
Harv Rev Psychiatry; 2001; 9(1):23-32. PubMed ID: 11159930
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
Bowden C
J Affect Disord; 2004 Apr; 79 Suppl 1():S9-14. PubMed ID: 15121342
[TBL] [Abstract][Full Text] [Related]
27. [The treatment of mood stabilizers in children and adolescents suffering from bipolar affective disorder].
Green T; Shoval G; Weizman A
Harefuah; 2005 Nov; 144(11):810-5, 821. PubMed ID: 16358659
[TBL] [Abstract][Full Text] [Related]
28. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
[TBL] [Abstract][Full Text] [Related]
29. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
[TBL] [Abstract][Full Text] [Related]
30. Lithium for maintenance treatment of mood disorders.
Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
[TBL] [Abstract][Full Text] [Related]
31. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
[TBL] [Abstract][Full Text] [Related]
32. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.
García-Blanco A; García-Portilla MP; Fuente-Tomás L; Batalla M; Sánchez-Autet M; Arranz B; Safont G; Arqués S; Livianos L; Sierra P
J Sex Med; 2020 May; 17(5):930-940. PubMed ID: 32139195
[TBL] [Abstract][Full Text] [Related]
33. Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
Chu CS; Lin CH; Lan TH; Chou PH
J Affect Disord; 2018 Feb; 227():79-81. PubMed ID: 29053979
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service.
Paterniti S; Bisserbe JC
BMC Psychiatry; 2013 Aug; 13():211. PubMed ID: 23941445
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
Peselow ED; Clevenger S; IsHak WW
Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex.
Cancelier K; Gomes LM; Carvalho-Silva M; Teixeira LJ; Rebelo J; Mota IT; Arent CO; Mariot E; Kist LW; Bogo MR; Quevedo J; Scaini G; Streck EL
Mol Neurobiol; 2017 Aug; 54(6):3935-3947. PubMed ID: 27246566
[TBL] [Abstract][Full Text] [Related]
37. Predictors of response to mood stabilizers.
Calabrese JR; Fatemi SH; Kujawa M; Woyshville MJ
J Clin Psychopharmacol; 1996 Apr; 16(2 Suppl 1):24S-31S. PubMed ID: 8707997
[TBL] [Abstract][Full Text] [Related]
38. Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?
Li X; Ketter TA; Frye MA
J Affect Disord; 2002 May; 69(1-3):1-14. PubMed ID: 12103447
[TBL] [Abstract][Full Text] [Related]
39. Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders.
Osete JR; Akkouh IA; de Assis DR; Szabo A; Frei E; Hughes T; Smeland OB; Steen NE; Andreassen OA; Djurovic S
Mol Psychiatry; 2021 Nov; 26(11):6789-6805. PubMed ID: 34075196
[TBL] [Abstract][Full Text] [Related]
40. Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability.
Martinotti G; Montemitro C; Pettorruso M; Viceconte D; Alessi MC; Di Carlo F; Lucidi L; Picutti E; Santacroce R; Di Giannantonio M
Expert Opin Pharmacother; 2019 Sep; 20(13):1575-1588. PubMed ID: 31150304
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
